Danaher (NYSE: DHR) awards 12,286 stock options to VP Bouda
Rhea-AI Filing Summary
Danaher Corporation granted VP and Chief Accounting Officer Christopher Bouda 12,286 employee stock options on August 4, 2026. Each option permits the purchase of one share of common stock at a $194.78 exercise price and expires on August 4, 2036. Fifty percent of the options become exercisable on each of the fourth and fifth anniversaries of the August 4, 2026 grant date, and Bouda holds all 12,286 options directly following this award.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Bouda Christopher
Role
VP, Chief Accounting Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee stock option (right to buy) F1, F2 | 12,286 | $0.00 | $0.00 |
Holdings After Transaction:
Employee stock option (right to buy) — 12,286 shares (Direct)
Footnotes (2)
- F1. On the date indicated, Danaher Corporation granted the reporting person employee stock options in the indicated amount in connection with the Issuer's Long-Term Growth Program, as previously reported in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 3, 2026.
- F2. Fifty percent of the options granted become exercisable on each of the fourth and fifth anniversaries of the grant date, which is August 4, 2026.
Key Figures
Employee stock options granted: 12,286 options
Exercise price: $194.78 per share
Expiration date: 2036-08-04
+3 more
6 metrics
Employee stock options granted
12,286 options
Grant to Christopher Bouda on 2026-08-04
Exercise price
$194.78 per share
Conversion or exercise price of granted options
Expiration date
2036-08-04
Option expiration for Bouda’s grant
Underlying shares
12,286 shares
Common stock underlying the employee stock options
Post-transaction option holdings
12,286 options
Total options held directly after the grant
Vesting schedule
50% on 4th and 5th anniversaries
Exercisability of options from 2026-08-04 grant
Key Terms
Employee stock option (right to buy), Long-Term Growth Program, Current Report on Form 8-K, exercisable
4 terms
Employee stock option (right to buy) financial
"security title is listed as Employee stock option (right to buy)"
Long-Term Growth Program financial
"granted the reporting person employee stock options ... in connection with the Issuer's Long-Term Growth Program"
Current Report on Form 8-K regulatory
"as previously reported in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission"
A current report on Form 8-K is a document that publicly traded companies file to promptly share important news or events that could affect their financial position or stock price, such as major business changes or legal issues. It helps investors stay informed about timely developments, allowing them to make better decisions about buying or selling shares.
exercisable financial
"Fifty percent of the options granted become exercisable on each of the fourth and fifth anniversaries"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did insider Christopher Bouda report in the latest Form 4 for DHR?
Christopher Bouda reported receiving 12,286 employee stock options from Danaher. The options are exercisable for an equal number of common shares at a $194.78 exercise price and were granted under Danaher’s Long-Term Growth Program on August 4, 2026.
What is the exercise price and structure of the stock options granted to Christopher Bouda at DHR?
The granted options have a $194.78 per-share exercise price. They cover 12,286 shares of Danaher common stock and expire on August 4, 2036, providing long-dated upside exposure tied to the company’s Long-Term Growth Program.
How do the DHR stock options granted to Christopher Bouda vest over time?
The options vest in two equal installments, with 50% becoming exercisable on each of the fourth and fifth anniversaries of the August 4, 2026 grant date. This creates a multi-year incentive aligned with longer-term company performance.
How many Danaher (DHR) options does Christopher Bouda hold after this transaction?
Following this grant, Christopher Bouda directly holds 12,286 employee stock options. This entire reported position comes from the August 4, 2026 award tied to Danaher’s Long-Term Growth Program as described in the footnotes.
Were the reported DHR Form 4 option grants made under a Rule 10b5-1 trading plan?
No. The Form 4’s Rule 10b5-1 checkbox is not marked as affirmative, and the footnotes describe the transaction as an employee stock option grant under Danaher’s Long-Term Growth Program, without referencing a trading plan.
What program at Danaher (DHR) is associated with Christopher Bouda’s option grant?
The options were granted in connection with Danaher’s Long-Term Growth Program. The award and its terms were previously described in a Current Report on Form 8-K filed with the SEC on August 3, 2026, according to the footnotes.